Page last updated: 2024-11-02

moxonidine and Syndrome

moxonidine has been researched along with Syndrome in 4 studies

moxonidine: structure given in first source

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
"Moxonidine has been shown to improve glucose tolerance in man, probably by two different mechanisms, i."2.40Therapy of hypertension and metabolic syndrome: today's standard and tomorrow's perspectives. ( Hansson, L, 1998)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herholz, J1
Crisponi, L1
Mallick, BN1
Rutsch, F1
Krentz, AJ1
Evans, AJ1
Hansson, L1
Schachter, M1

Reviews

2 reviews available for moxonidine and Syndrome

ArticleYear
Therapy of hypertension and metabolic syndrome: today's standard and tomorrow's perspectives.
    Blood pressure. Supplement, 1998, Volume: 3

    Topics: Antihypertensive Agents; Humans; Hyperlipidemias; Hypertension; Imidazoles; Insulin Resistance; Obes

1998
Metabolic effects of moxonidine and other centrally acting antihypertensives.
    Diabetes, obesity & metabolism, 1999, Volume: 1, Issue:6

    Topics: Animals; Antihypertensive Agents; Diabetes Complications; Humans; Hypertension; Imidazoles; Insulin

1999

Other Studies

2 other studies available for moxonidine and Syndrome

ArticleYear
Successful treatment of cold-induced sweating in Crisponi syndrome and its possible mechanism of action.
    Developmental medicine and child neurology, 2010, Volume: 52, Issue:5

    Topics: Abnormalities, Multiple; Analgesics, Non-Narcotic; Cold Temperature; Female; Fever; Follow-Up Studie

2010
Selective imidazoline receptor agonists for metabolic syndrome.
    Lancet (London, England), 1998, Jan-17, Volume: 351, Issue:9097

    Topics: Antihypertensive Agents; Humans; Hypertension; Imidazoles; Imidazoline Receptors; Insulin Resistance

1998